MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution
about
sameAs
Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null miceTrisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteinsCDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tailDevelopmental Dynamics of Rett SyndromeIllness Severity, Social and Cognitive Ability, and EEG Analysis of Ten Patients with Rett Syndrome Treated with Mecasermin (Recombinant Human IGF-1).Insulin-Like Growth Factor 1 and Related Compounds in the Treatment of Childhood-Onset Neurodevelopmental DisordersDendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutationsBdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutationsSafety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains.Repeated insulin-like growth factor 1 treatment in a patient with rett syndrome: a single case study.Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice.Genetic insights into the functional elements of language.Guided eating or feeding: three girls with Rett syndrome.Upregulation of insulin-like growth factor binding protein 3 in astrocytes of transgenic mice that express Borna disease virus phosphoprotein.First case report of Rett syndrome in the Azeri Turkish population and brief review of the literatureAnxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales.Applying the ethoexperimental approach to neurodevelopmental syndrome research reveals exaggerated defensive behavior in Mecp2 mutant mice.Changing the perspective on early development of Rett syndromeEpigenetics and Neural developmental disorders: Washington DC, September 18 and 19, 2006Exposure to caregiver maltreatment alters expression levels of epigenetic regulators in the medial prefrontal cortex.Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autismNeurobiologically-based treatments in Rett syndrome: opportunities and challenges.Temporal- and Location-Specific Alterations of the GABA Recycling System in Mecp2 KO Mouse Brains.Detecting autonomic response to pain in Rett syndrome.Modification of spectral features by nonhuman primatesIsoform-specific anti-MeCP2 antibodies confirm that expression of the e1 isoform strongly predominates in the brain.Brain derived neurotrophic factor and serotonin transporter binding as markers of clinical response to fluoxetine therapy in children with autism.Longitudinal hand function in Rett syndrome.Rett syndrome: an eye-tracking study of attention and recognition memory.Structural and functional differences in the barrel cortex of Mecp2 null mice.Neuronal cytoskeletal gene dysregulation and mechanical hypersensitivity in a rat model of Rett syndrome.En route to disentangle the impact and neurobiological substrates of early vocalizations: learning from Rett syndrome.Social impairments in Rett syndrome: characteristics and relationship with clinical severity.Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome.Transcriptome level analysis in Rett syndrome using human samples from different tissues.
P2860
Q21131923-55FEDA5F-32D8-445F-87CD-D283ECD6899EQ24622025-DD44F922-DA36-4CF8-9371-57961CE077F6Q24651382-6D327B1F-AA77-4204-861E-26943311931EQ26768284-A0145112-2FB9-4700-ABBC-E1B72B837F1BQ27312920-3A0C267E-0120-4B4C-8A77-96D40309F821Q28069589-6DE7F6F4-DB2F-47A8-81F8-FE4C2D7D88B8Q28909716-6DF68040-379F-4FF1-935A-BBC53D068791Q28941188-B84BF42F-FF3A-46B9-99C9-B5BF6913F43FQ30574939-45E07BD5-1298-4B08-B747-6B68E356A1D6Q33569805-62403DF0-BB32-405C-8A39-1C9F07DAB2E7Q33702137-7361F685-421F-4631-8A52-3E6C3B180AF7Q34004048-984DA89B-906E-45C4-B269-E9EDE6B20FB9Q34349576-6F9C6D75-12DD-4C1C-B4B7-7830A8225A74Q34847470-E0CCFC4A-BFCE-4EC8-A684-9F29B8D98CA7Q35076913-0B029F79-E278-430F-9BEB-80F392A9816AQ35115507-4DE4428D-E422-4C86-8CC9-EB8D4B997B19Q36063019-4468FC2B-6976-4CA1-A174-943EC4F0C2B9Q36095982-29EE5D71-1E3C-45D1-81B4-1C9716CEBD6FQ36708337-2DFDB855-03F4-4917-92D2-A1873523422AQ37238104-184DC5E6-0D70-4BD1-B9B1-E1F54F460C5CQ37378167-D614C226-0DF1-4343-8B81-A180DD94EF9DQ37460218-77C37E2D-9217-40F1-8BC1-7C8DD877C7D8Q37558440-74B101B2-3875-4D9D-BC92-6242FD858524Q38682455-36B7C520-D6E2-42F3-A603-9EBD640C9C1FQ38954448-52958A50-99FF-42DF-B96A-9FA560EFFD81Q41152831-DBA8170A-1997-4581-A4B4-5AFE4C1F8E71Q41873737-A01E7122-9760-4651-9303-4135FD1C1B2FQ44295145-3F475FCA-993E-4F0B-9C57-B7424269DF2BQ45279001-6155C4F6-90C2-455C-A57A-B4C84D220624Q46162463-F7C13FDE-225E-4DE1-9E19-07F115F50037Q47878842-C96B23A1-9BB9-465E-B0F7-DF4161B5A0AFQ48006757-19A7E4BC-850C-46CF-8F30-F7A3EA968F12Q48410101-BE361817-EAA1-486F-A393-B4668B7F7B41Q50312318-F05D0AA3-040A-4DFE-8C7E-2B0B9C32D78DQ54943580-7D5360DA-635B-484D-A02E-15F427A16E42Q55654628-E893FDC4-2E2D-4C2E-BCD9-75095E7BDF2A
P2860
MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
MeCP2 expression and function ...... genesis and clinical evolution
@ast
MeCP2 expression and function ...... genesis and clinical evolution
@en
MeCP2 expression and function ...... genesis and clinical evolution
@nl
type
label
MeCP2 expression and function ...... genesis and clinical evolution
@ast
MeCP2 expression and function ...... genesis and clinical evolution
@en
MeCP2 expression and function ...... genesis and clinical evolution
@nl
prefLabel
MeCP2 expression and function ...... genesis and clinical evolution
@ast
MeCP2 expression and function ...... genesis and clinical evolution
@en
MeCP2 expression and function ...... genesis and clinical evolution
@nl
P2093
P921
P3181
P1476
MeCP2 expression and function ...... genesis and clinical evolution
@en
P2093
Mary E Blue
Mary E. Blue
Michael V Johnston
Michael V. Johnston
Walter E Kaufmann
Walter E. Kaufmann
P304
P3181
P356
10.1016/J.BRAINDEV.2004.10.008
P407
P577
2005-11-01T00:00:00Z